Tiny OncoSec Surges on Promising Phase II Melanoma Data Post author:Sam Post published:November 7, 2017 Post category:BioPharma The updated data will be presented at the 2017 Society for Immunotherapy of Cancer Annual Meeting. Source: BioSpace You Might Also Like GlaxoSmithKline Is Taking a Tough Approach to Budgets March 20, 2018 Flagship Pioneering Secures $618M for Life Science Startup Mission December 19, 2017 Biotech Startup Rubius to Double Footprint With New Kendall Square Lease February 11, 2018